Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rydén, M.
Right arrow Articles by Arner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rydén, M.
Right arrow Articles by Arner, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 51:1601-1608, 2002
© 2002 by the American Diabetes Association, Inc.

Effect of the (C825T) Gß3 Polymorphism on Adrenoceptor-Mediated Lipolysis in Human Fat Cells

Mikael Rydén, Gary Faulds, Johan Hoffstedt, Anders Wennlund, and Peter Arner

From the Department of Medicine, Karolinska Institutet and Clinical Research Center at the Center of Metabolism and Endocrinology, Huddinge Hospital, Huddinge, Sweden

A common Gß3 gene polymorphism (C825T) influences G protein receptor-mediated signal transduction. We investigated whether this polymorphism influences lipolysis in isolated subcutaneous fat cells from 114 healthy obese subjects. The Gß3 protein content was markedly decreased in adipocytes of TT carriers, but the alternatively spliced short form of Gß3 previously shown in platelets of 825T carriers was not detected. Fat cells of TT carriers showed a significant 10-fold decrease in the half-maximum effective concentration of agonists selective for lipolytic ß1- and ß2-adrenoceptors as well as for the antilipolytic {alpha}2A-adrenoceptor. In TT carriers, maximum ß-adrenoceptor agonist-stimulated lipolysis was decreased, but the maximum antilipolytic effect of {alpha}2-adrenoceptors was less marked. Norepinephrine induced adipocyte lipolysis and circulating fasting levels of free fatty acids and glycerol were reduced by half in TT carriers. The polymorphism did not influence the adipocyte content of {alpha}2A-adrenoceptors, ß2-adrenoceptors, G{alpha}i, or G{alpha}s. In conclusion, the C825T variant of Gß3 influences lipolysis. Adipocytes of TT carriers have a lower 3 protein content and a decreased function of native Gs- as well as Gi-coupled adrenoceptors, which reduces the lipolytic effect of catecholamines. These data differ from those obtained in other cell systems that have shown increased expression of an alternative spliced Gß3 variant and enhanced G protein signaling in 825T carriers, indicating that the polymorphism has cell type-specific effects that may be of importance for type 2 diabetes and other insulin-resistant conditions.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Kolak, J. Westerbacka, V. R. Velagapudi, D. Wagsater, L. Yetukuri, J. Makkonen, A. Rissanen, A.-M. Hakkinen, M. Lindell, R. Bergholm, et al.
Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity
Diabetes, August 1, 2007; 56(8): 1960 - 1968.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. L. Kirstein and P. A. Insel
Autonomic Nervous System Pharmacogenomics: A Progress Report
Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
W. Siffert
Effects of the G protein {beta}3-subunit gene C825T polymorphism: should hypotheses regarding the molecular mechanisms underlying enhanced G protein activation be revised? Focus on "A splice variant of the G protein {beta}3-subunit implicated in disease states does not modulate ion channels"
Physiol Genomics, April 16, 2003; 13(2): 81 - 84.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.